Current concepts of pathophysiology, epidemiology and classification of pruritus

Srpski Arhiv za Celokupno Lekarstvo

Volumn 142, Issue 1-2, 2014, Pages 106-112

  Jovanović, Marina ^a,b  

^a UNIVERSITY OF NOVI SAD   (Serbia)

^b Clinic of Dermatovenereology Diseases Clinical Center of Vojvodina ^*  (Serbia)

Author keywords

Comorbidity; Prevalence; Pruritus; Skin diseases

Indexed keywords

ADVERSE DRUG REACTION; ADVERSE EFFECTS; CHOLESTASIS; CLASSIFICATION; COMPLICATION; HUMAN; NEUROLOGIC DISEASE; PRURITUS; RENAL REPLACEMENT THERAPY; SKIN DISEASE; SOMATOFORM DISORDER; SYSTEMIC SCLEROSIS;

CHOLESTASIS; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; HUMANS; NERVOUS SYSTEM DISEASES; PRURITUS; RENAL DIALYSIS; SCLERODERMA, SYSTEMIC; SKIN DISEASES; SOMATOFORM DISORDERS;

EID: 84940032157     PISSN: 03708179     EISSN: None     Source Type: Journal    
DOI: 10.2298/SARH1402106J     Document Type: Article

References (64)

1. Liddell K. Hippocrates of Cos (460-377 BC). Clin Exp Dermatol. 2000; 25:86-8.
2. Hafenreffer S. De pruriti, in Nosodochium, in quo cutis, eiqe adhaerentium partium, affectus omnes singulari methodo et cognoscendi et curandi fidelissime traduntur. Ulm: B Kuehn; 1660. p.98-102.
3. Bernhard JD. Itch and pruritus: what are they and how should itches be classified? Dermatol Ther. 2005; 18:288-91.
4. Weisshaar E, Kucenic MJ, Fleischer JR. Pruritus a review. Acta Derm Venereol Suppl. 2003; (213):5-32.
5. Greaves MW. Pathogenesis and treatment of pruritus. Curr Allergy Asthma Rep. 2010; 10:236-42.
6. Schmelz M, Schmidt R, Bickel A, Handwerker HO, Torebjork HE. Specific C-receptors for itch in human skin. J Neurosci. 1997; 17:8003-8.
7. Andrew D, Craig AD. Spinothalamic lamina I neurons selectively sensitive to histamine: a central neural pathway for itch. Nat Neurosci. 2001; 4:72-7.
8. Ständer S, Raap U, Weisshaar E, Schmelz M, Mettang T, Handwerker H, et al. Pathogenesis of pruritus. J Dtsch Dermatol Ges. 2011; 9:456-63.
9. Davidson S, Zhang X, Yoon CH, Khasabov SG, Simone DA, Giesler GJ Jr. The itch-producing agents histamine and cowhage activate separate populations of primate spinothalamic tract neurons. J Neurosci. 2007; 27:10007-14.
10. Imamachi N, Park GH, Lee H, Anderson DJ, Simon MI, Basbaum AI, et al. TRPV1-expressing primary afferents generate behavioral responses to pruritogens via multiple mechanisms. Proc Natl Acad Sci U S A. 2009; 106:11330-5.
11. Steinhoff M, Biro T. A TR(I)P to pruritus research: role of TRPV3 in inflammation and itch. J Invest Dermatol. 2009; 129:531-5.
12. McNeil B, Dong X. Peripheral mechanisms of itch. Neurosci Bull. 2012; 28(2):100-10.
13. Yosipovitch G, Samuel L. Neuropathic and psychogenic itch. Dermatol Ther. 2008; 21:32-41.
14. Cowden JM, Zhang M, Dunford PJ, Thurmond RL. The histamine H4 receptor mediates inflammation and pruritus in Th2-dependent dermal inflammation. J Invest Dermatol. 2010; 130:1023-33.
15. Gutzmer R, Mommert S, Gschwandtner M, Zwingmann K, Stark H, Werfel T. The histamine H4 receptor is functionally expressed on T(H)2 cells. J Allergy Clin Immunol. 2009; 123:619-25.
16. Soh UJ, Dores MR, Chen B, Trejo J. Signal transduction by protease-activated receptors. Br J Pharmacol. 2010; 160(2):191-203.
17. Ständer S, Siepmann D, Herrgott I, Sunderkötter C, Luger TA. Targeting the neurokinin receptor 1 with aprepitant: a novel antipruritic strategy. PLOS One. 2010; 5:e10968.
18. Metz M, Gundmann S, Stander S. Pruritus: an overview of current concepts. Vet Dermatol. 2011; 22:121-31.
19. Phan NQ, Bernhard JD, Luger TA, Ständer S. Antipruritic treatment with systemic μ-opioid receptor antagonists: a review. J Am Acad Dermatol. 2010; 63:680-8.
20. Reich A, Szepietowski JC. Opioid-induced pruritus: an update. Clin Exp Dermatol. 2010; 35:2-6.
21. Kumagai H, Ebata T, Takamori K, Muramatsu T, Nakamoto H, Suzuki H. Effect of a novel kappa-receptor agonist, nalfurafine hydrochloride, on severe itch in 337 haemodialysis patients: a phase III, randomized, double-blind, placebo- controlled study. Nephrol Dial Transplant. 2010; 25:1251-7.
22. Kupczyk P, Reich A, Szepietowski JC. Cannabinoid system in the skin - a possible target for future therapies in dermatology. Exp Dermatol. 2009; 18:669-79.
23. Sun YG, Chen ZF. A gastrin-releasing peptide receptor mediates the itch sensation in the spinal cord. Nature. 2007; 448(7154):700-3.
24. Dalgard F, Svensson A, Holm JO, Sundby J. Self-reported skin morbidity in Oslo: Associations with sociodemographic factors among adults in a cross-sectional study. Br J Dermatol. 2004; 151:452-7.
25. Wolkenstein P, Grob JJ, Bastuji-Garin S, Ruszczynski S, Roujeau JC, Revuz J. French people and skin diseases: results of a survey using a representative sample. Arch Dermatol. 2003; 139:1614-9.
26. Matterne U, Strassner T, Apfelbacher CJ, Diepgen TL, Weisshaar E. Measuring the prevalence of chronic itch in the general population: a pilot study. Acta Derm Venereol. 2009; 89:250-6.
27. Murdoch ME, Asuzu MC, Hagan M, Makunde WH, Ngoumou P, Ogbuagu KF, et al. Onchocerciasis: the clinical and epidemiological burden of skin disease in Africa. Ann Trop Med Parasitol. 2002; 96:283-96.
28. Roy A, Pickar D, Paul S. Doran A, Chrousos GP, Gold PW. CSF corticotropin-releasing hormone in depressed patients and normal control subjects. Am J Psychiatry. 1987; 144:641-5.
29. Halvorsen JA, Dalgard F, Thoresen M, Bjertness E, Lien L. Itch and mental distress: a cross-sectional study among late adolescents. Acta Derm Venereol. 2009; 89:39-44.
30. Senturk N, Ozkaya O, Aytekin S, Bek K, Acikgoz Y, Aydin F, et al. Characteristics of pruritus in children on peritoneal dialysis. Nephron Clin Pract. 2008; 109:168-72.
31. Reich A, Stander S, Szepietowski JC. Pruritus in elderly. Clin Dermatol. 2011; 29:15-23.
32. Black MM, Ambros-Rudolph C, Edwards L, Lynch P, editors. Obstetric and Gynaecologic Dermatology. 3rd ed. London: Mosby Elsevier; 2008.
33. Weisshaar E, Apfelbacher C, Jager G, Zimmermann E, Bruckner T, Diepgen TL, et al. Pruritus as a leading symptom: clinical characteristics and quality of life in German and Ugandan patients. Br J Dermatol. 2006; 155:957-64.
34. Jovanović M, Poljački M, Mimica-Dukić N, Boža P, Vujanović LJ, Djuran V, et al. Sesquiterpene lactone mix patch testing supplemented with dandelion extract in patients with allergic contact dermatitis, atopic dermatitis and non-allergic chronic inflammatory skin diseases. Contact Dermatitis. 2004; 51:101-10.
35. Jovanović M, Mimica-Dukić N, Poljački M, Boža P. Erythema multiforme due to contact with weeds: a recurrence after patch testing. Contact Dermatitis. 2003; 48:17-25.
36. Jovanović M, Oliwiecki S, Beck MH. Occupational contact urticaria from beef associated with hand eczema. Contact Dermatitis. 1992; 27:188-9.
37. Jovanović M, Poljački M, Djuran V, Vujanović LJ, Sente R, Stojanović S. Kontaktna senzibilizacija izazvana Compositae biljkama kod obolelih od atopijskog dermatitisa. Med Pregl. 2004; 57:209-18.
38. Jovanović M, Boža P, Karadaglić DJ, Brkić S, Petrović A, Mimica-Dukić N, et al. Contact sensitivity in patients with psoriasis in Vojvodina. Int Arch Allergy Immunol. 2009; 148:311-20.
39. Dlova NC, Mosam A. Inflammatory noninfectious dermatoses of HIV. Dermatol Clin. 2006; 24:439-48.
40. Jovanović M, Karadaglić DJ, Brkić S. Contact urticaria and allergic contact dermatitis to lidocaine in a patient sensitive to benzocaine and propolis. Contact Dermatitis. 2006; 54:124-6.
41. Yosipovitch G, Goon AT, Wee J, Chan YH, Zucker I, Goh CL. Itch characteristics in Chinese patients with atopic dermatitis using a new questionnaire for the assessment of pruritus. Int J Dermatol. 2002; 41:212-6.
42. Yosipovitch G, Goon A, Wee J, Chan YH, Goh CL. The prevalence and clinical characteristics of pruritus among patients with extensive psoriasis. Br J Dermatol. 2000; 143:969-73.
43. Szepietowski JC, Reich A, Wisnicka B. Pruritus and psoriasis. Br J Dermatol. 2004; 151:1284.
44. Zamirska A, Reich A, Berny-Moreno J, Salomon J, Szepietowski JC. Vulvar pruritus and burning sensation in women with psoriasis. Acta Derm Venereol. 2008; 88:132-5.
45. Amatya B, Wennersten G, Nordlind K. Patients' perspective in chronic plaque psoriasis: a questionnaire-based study. J Eur Acad Dermatol Venereol. 2008; 22:822-6.
46. Conrad R, Geiser F, Haidl G, Hutmacher M, Liedtke R, Wermter F. Relationship between anger and pruritus perception in patients with chronic idiopathic urticaria and psoriasis. J Eur Acad Dermatol Venereol. 2008; 22:1062-9.
47. Van Loey NE, Bremer M, Faber AW, Middelkoop E, Nieuwenhuis MK. Itching following burns: epidemiology and predictors. Br J Dermatol. 2008; 158:95-100.
48. Ferm I, Magnus S, Wallengren J. Somatic and psychiatric comorbidity in patients with chonic pruritus. Acta Derm Venereol. 2010; 90:395-400.
49. Sommer F, Hensen P, Bockenholt B, Metze D, Luger TA, Stander S. Underlying diseases and co-factors in patients with severe chronic pruritus: a 3-year retrospective study. Acta Derm Venereol. 2007; 87:510-6.
50. Afifi Y, Aubin F, Puzenat E, Degouy A, Aubrion D, Hassam B, et al. Enquête étiologique d'un prurit sine materia: étude prospective d'une série de 95 patients. Rev Med Interne. 2004; 25:490-3.
51. Özdemir M, Tuzun Y. Herpes zoster and pruritus. Int J Dermatol. 2004; 43:779-80.
52. Schmidt E, Rose C, Mulyowa GK, Jager G. Dermatologie an der Universitätsklinik Mbarara, Uganda. J Dtsch Dermatol Ges. 2004; 2:920-7.
53. Herzberg U, Sagen J. Peripheral nerve exposure to HIV viral envelope protein gp120 induces neuropathic pain and spinal gliosis. J Neuroimmunol. 2001; 116:29-39.
54. Razeghi E, Eskandari D, Ganji MR, Meysamie A P, Togha M, Khashayar P. Gabapentin and uremic pruritus in haemodyalisis patients. Ren Fail. 2009; 31:85-90.
55. Davis M P, Frandsen JL, Walsh D, Andersen S, Taylor S. Mirtazapine for pruritus. J Pain Symptom Manage. 2003; 25:288-91.
56. Cribier B, Santinelli F, Schmitt C, Stoll-Keller F, Grosshans E. Should patients with pruritus be tested for hepatitis C virus infection? A case controlled study. Br J Dermatol. 2000; 142:1249-50.
57. Weisshaar E, Dalgard Florence. Epidemiology of itch: adding to the burden of skin morbidity. Acta Derm Venereol. 2009; 89:339-50.
58. Yosipovitch G. Chronic pruritus: a paraneoplastic sign. Dermatol Ther. 2010; 23:590-6.
59. Arnold LM, Auchenbach MB, McElroy SL. Psychogenic excoriation. Clinical features, proposed diagnostic criteria, epidemiology and approaches to treatment. CNS Drugs. 2001; 15:351-9.
60. Stander S, Weisshaar E, Mattang T, Szepietowski JC, Carstens E, Ikoma A, et al. Clinical classification of itch: a position paper of the international forum for the study of itch. Acta Derm Venereol. 2007;87:291-4.
61. Tey HL, Wallengren J, Yosipovitch G. Psychosomatic factors in pruritus. Clin Dermatol. 2013;31:31-40.
62. Misery L, Wallengren DJ, Weisshaar E, Zalewska A. Validation of diagnostic criteria of functional itch disorder or psychogenic pruritus. Arch Derm Venereol. 2008; 88:503-4.
63. Misery L, Alexandre S, Dutray S, Chastaing M, Consoli SG, Audra H, et al. Functional itch disorder or psychogenic pruritus: suggested diagnosis criteria from the French psychodermatology group. Acta Derm Venereol. 2007; 87:341-4.
64. Jovanović M. Manifestations of contact allergy. Srp Arh Cel Lek. 2012; 140(11-12):786-91.